Pdt Partners, LLC Xenon Pharmaceuticals Inc. Transaction History

Pdt Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$13.65 - $21.31 $224,556 - $350,570	-16,451 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.49 - $16.04 $11,217 - $18,959	-1,182 Reduced 6.7%	16,451 $253,000
Q3 2020 Nov 16, 2020	SELL	$10.82 - $13.35 $130,337 - $160,814	-12,046 Reduced 40.59%	17,633 $195,000
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $77,493 - $113,091	7,590 Added 34.36%	29,679 $372,000
Q1 2020 May 15, 2020	BUY	$8.08 - $17.57 $178,479 - $388,103	22,089 New	22,089 $250,000
Q4 2018 Feb 14, 2019	SELL	$5.61 - $12.62 $90,175 - $202,853	-16,074 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$9.0 - $14.9 $15,867 - $26,268	-1,763 Reduced 9.88%	16,074 $212,000
Q2 2018 Aug 14, 2018	BUY	$4.8 - $9.2 $85,617 - $164,100	17,837 New	17,837 $164,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.